Precision Xtract Covers Economic Assessment of Novel Gene and Cellular Therapies in the Journal of Clinical Pathways


Phil Cyr and Larry Blandford offer their experience and insights on developing health economic models for gene and cellular therapies. 

To read the full article, click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.